Contact Information:
Gonzalo Ladreda
info@upfrontdiagnostics.com
+44 7597582767
http://upfrontdiagnostics.com/
PRESTO Industry Partner
Upfront Diagnostics, a UK-Cambridge based company introduces LVOne, the world’s first point-of-care rapid diagnostic test designed to identify Large Vessel Occlusion (LVO) strokes in minutes. Current delays in identifying thrombectomy-eligible patients lead to unnecessary transfers and poor outcomes. Using a proprietary biomarker panel, LVOne analyses finger-prick blood for biomarkers to accurately identify LVOs within 10 minutes. Their technology is supported by robust clinical evidence from trials in both the UK and the US.
Upfront Diagnostics is ISO13485 certified, ensuring rigorous quality standards. The LVOne is approved in the UK and already implemented in parts of the UK. LVOne is poised to redefine acute stroke care by ensuring the right patient gets the correct treatment on time.
